e-learning
resources
Paris 2018
Wednesday, 19.09.2018
Eosinophils in airway disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Peripheral eosinophils and mortality in COPD patients over nine years
R. Prudente (Botucatu, Brazil), C. Mesquita (Botucatu, Brazil), R. Ferrari (Botucatu, Brazil), E. Franco (Botucatu, Brazil), S. Tanni (Botucatu, Brazil)
Source:
International Congress 2018 – Eosinophils in airway disease
Session:
Eosinophils in airway disease
Session type:
Oral Presentation
Number:
5383
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Prudente (Botucatu, Brazil), C. Mesquita (Botucatu, Brazil), R. Ferrari (Botucatu, Brazil), E. Franco (Botucatu, Brazil), S. Tanni (Botucatu, Brazil). Peripheral eosinophils and mortality in COPD patients over nine years. 5383
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Definition and history of sarcoidosis
Evidence of early abnormal airways’ inflammation in children with type 1 diabetes
Related content which might interest you:
Blood eosinophils and exacerbation rate in COPD patients over three years
Source: International Congress 2018 – Biomarkers and lung function in airway disease
Year: 2018
Correlation between sputum and blood eosinophils in asthmatic and COPD patients with comorbidities.
Source: International Congress 2018 – Airway disease: recent discoveries
Year: 2018
Blood vs sputum eosinophils as predictors of exacerbations in a cohort of severe asthmatics
Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD
Year: 2018
The relationship between blood neutrophils, blood eosinophils and exacerbations of COPD – Results from the TIE-study
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
The rate of re-exacerbation in patients hospitalized with eosinophil and non-eosinophilic COPD relapses
Source: Virtual Congress 2020 – Phenotypes of obstructive diseases
Year: 2020
Blood eosinophil count and exacerbation risk in patients with COPD
Source: Eur Respir J, 50 (1) 1700761; 10.1183/13993003.00761-2017
Year: 2017
Analysis of peripheral blood lymphocytes in asthma and chronic obstructive pulmonary disease (COPD) patients
Source: Annual Congress 2010 - Lung cell biology and immunology
Year: 2010
Peripheral neutrophil stiffness is increased in COPD severe exacerbations
Source: Annual Congress 2012 - COPD monitoring in stable disease and during exacerbation
Year: 2012
Peripheral neutrophil stiffness in severe COPD exacerbations
Source: Annual Congress 2011 - COPD: human studies
Year: 2011
Stability of eosinophils in blood in patients with chronic obstructive pulmonary diseasee (COPD) and one hospital admission
Source: Virtual Congress 2020 – COPD : inhaled corticosteroids, bronchodilators and eosinophils
Year: 2020
Association between blood eosinophil count and risk of exacerbations in patients with COPD
Source: International Congress 2017 – Biomarker-based asthma control
Year: 2017
Activated neutrophils are increased in bronchial biopsies from patients with severe COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 718s
Year: 2004
Pharmacodynamic effect of benralizumab on blood basophils and serum biomarkers in adults with COPD with sputum eosinophilia
Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD
Year: 2015
Stability of blood eosinophils over time in patients with asthma
Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations
Year: 2021
Blood eosinophil count and risk of pneumonia hospitalisations in individuals with COPD
Source: Eur Respir J, 51 (5) 1800120; 10.1183/13993003.00120-2018
Year: 2018
Can blood eosinophils predict sputum eosinophils in stable COPD?
Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease
Year: 2015
Treatment of moderate-severe asthma with omalizumab is associated with a decrease in peripheral blood eosinophils
Source: Eur Respir J 2007; 30: Suppl. 51, 353s
Year: 2007
Blood eosinophils and outcomes in COPD
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016
Elevated blood eosinophils on admission for a severe exacerbation of COPD is not a predictor for survival
Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer
Year: 2017
Clinical factors associated with baseline blood eosinophils among patients with asthma or COPD: NOVELTY study
Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept